A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Capecitabine|DRUG: Sunitinib malate
Sponsor: Pfizer